Compile Data Set for Download or QSAR
maximum 50k data
Found 53 Enz. Inhib. hit(s) with all data for entry = 1905
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM346999(US10202388, Compound 1-3)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347038(US10202388, Compound 52A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347037(US10202388, Compound 49)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347036(US10202388, Compound 46)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347034(US10202388, Compound 45A-1)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347033(US10202388, Compound 45A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347022(US10202388, Compound 23A-2 | US10202388, Compound ...)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347020(US10202388, Compound 23A | US10202388, Compound 26...)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347018(US10202388, Compound 21 | US10202388, Compound 25)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347023(US10202388, Compound 23A-3)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM346996(US10202388, Compound 1)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347021(US10202388, Compound 23A-1)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347020(US10202388, Compound 23A | US10202388, Compound 26...)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347019(US10202388, Compound 22)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347044(US10202388, Compound 62A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347043(US10202388, Compound 61A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347041(US10202388, Compound 55)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347040(US10202388, Compound 53A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347006(US10202388, Compound 9)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347007(US10202388, Compound 10A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347008(US10202388, Compound 10A-2)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM346998(US10202388, Compound 1-2)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347012(US10202388, Compound 11A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347013(US10202388, Compound 11A-2)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347014(US10202388, Compound 14A)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347015(US10202388, Compound 13 | US10358451, Compound 10)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347016(US10202388, Compound 14A-4)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347018(US10202388, Compound 21 | US10202388, Compound 25)
Affinity DataIC50: <100nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTryptophan 2,3-dioxygenase(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347034(US10202388, Compound 45A-1)
Affinity DataIC50:  300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347039(US10202388, Compound 52B)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347035(US10202388, Compound 45A-4)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347002(US10202388, Compound 3)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347005(US10202388, Compound 8)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347004(US10202388, Compound 7)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTryptophan 2,3-dioxygenase(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347022(US10202388, Compound 23A-2 | US10202388, Compound ...)
Affinity DataIC50:  300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347024(US10202388, Compound 23A-4 | US10202388, Compound ...)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347042(US10202388, Compound 58)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347025(US10202388, Compound 23B | US10202388, Compound 26...)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347011(US10202388, Compound 10B)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTryptophan 2,3-dioxygenase(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347013(US10202388, Compound 11A-2)
Affinity DataIC50:  300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTryptophan 2,3-dioxygenase(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347023(US10202388, Compound 23A-3)
Affinity DataIC50:  300nMAssay Description:The TDO2 enzymatic assay was performed by UV absorption using a recombinant TDO2 and L-Tryptophan substrate. The UV absorption signal at 321 nm is co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347003(US10202388, Compound 4)
Affinity DataIC50:  300nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347032(US10202388, Compound 40)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347025(US10202388, Compound 23B | US10202388, Compound 26...)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347024(US10202388, Compound 23A-4 | US10202388, Compound ...)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347022(US10202388, Compound 23A-2 | US10202388, Compound ...)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347017(US10202388, Compound 14A-1)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347009(US10202388, Compound 10A-3)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347001(US10202388, Compound 2)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM347000(US10202388, Compound 1-4)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds described in this disclosure were dissolved in 10% DMSO to predefined concentration. All of the reactions were conducted at room temper...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: